Sunitinib malate in solitary fibrous tumor (SFT)
Annals of Oncology, 06/21/2012
Clinical Article
Stacchiotti S et al. – The findings suggest that sunitinib is active in solitary fibrous tumor (SFT). Response can be long–lasting.



